Silvia Riondino

11PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 28, 2024
The Use of Artificial Intelligence in Predicting Chemotherapy-Induced Toxicities in Metastatic Colorectal Cancer: A Data-Driven Approach for Personalized Oncology.

Eliza-Maria Froicu, Oriana-Maria Oniciuc, Vlad-Adrian Afrăsânie

|Apr 13, 2024
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?

Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica

|Sep 28, 2023
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.

Stefano Sganga, Silvia Riondino, Giovanni Maria Iannantuono

|Jun 10, 2023
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS

Vincenzo Formica, Cristina Morelli, Veronica Conca

|Jan 20, 2023
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?

Silvia Riondino, Vincenzo Formica, Elena Valenzi

|Dec 29, 2022
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series.

Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga

Pageof 2

Frequent Collaborators

7 joint publications

Mario Roselli

6 joint publications

Francesco Torino

5 joint publications

Roberto Rosenfeld

3 joint publications

Patrizia Ferroni